Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study

Go back to Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
(NASDAQ: KRYS) Delayed: 313.17 +1.67 (0.54%)
Previous Close $311.50    52 Week High $ 
Open $313.56    52 Week Low $ 
Day High $317.76    P/E N/A 
Day Low $312.00    EPS $ 
Volume 41,303